What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Volume Rate of Change

Score

-0.55

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 98 5.0 0.57% 1.04% 3.9% -3.5% 30.8%
SHORT 99 4.6 0.61% 1.11% 2.3% -4.8% -118.4%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

VOLUME RATE OF CHANGE


Last Signal:

BEARISH


Trading: SELL @ $1.805
Signal Strength: MEDIUM
Recommendation:

Opthea (ASX:OPT) currently has negative rate of change of -10%. This means the current volume is less than the price 14 days ago and therefore losing momentum.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement


Volume Rate of Change Volume (VROC) is an oscillator applied to volume rather than price and is calculated in the same manner as the Rate of Change (Price) indicator. VROC highlights increases in volume which normally occur at most significant market tops bottoms and breakouts.

Calculation: Volume Rate of Change (VROC):
1) ( Volume [today] - Volume [n days ago] ) / Volume [n days ago];


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Volume Rate of Change

Download
Company Close Change(%) Volume Value Signal
ISD Isentia 0.15 20.8 1,057,241 -42 BEARISH
ATL ASX 20 0.1 16.3 289,754 -49 BEARISH
VRL Village Roadshow 1.14 14 354,335 -56 BEARISH
SXY Senex Energy 0.17 13.8 12,737,087 -43 BEARISH
GTN GTN Resources 0.49 8.9 19,100 -14 BEARISH
PGC Paragon Care 0.13 8.7 1,392,228 -46 BEARISH
EWC Energy World Corporation 0.05 8.5 162,002 -70 BEARISH
URF Us Masters Residential Property Fund 0.27 8.2 97,913 -40 BEARISH
JHC Japara Healthcare 0.49 7.7 887,959 -62 BEARISH
FRI Finbar International 0.68 7.1 55,654 -14 BEARISH